Century Therapeutics, Inc. (IPSC) vs Ocugen, Inc. (OCGN)
- Century Therapeutics, Inc. IPSC 1.37 −8.67%
- Ocugen, Inc. OCGN 0.78 −3.70%
Century Therapeutics, Inc. and Ocugen, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Ocugen, Inc. are of similar size ($275.9M and $271.6M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −3.66%. Century Therapeutics, Inc. has the higher net margin (0.00% vs −1,786.3%) and the lower return on invested capital (−64.9% vs 0.00%). Across the 15 metrics below, Century Therapeutics, Inc. leads on 9 and Ocugen, Inc. on 6.
Valuation
Profitability
| Metric | IPSC | OCGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (1,504.43%) | 0.00% |
| Net margin | 0.00% | (1,786.27%) | 0.00% |
| Free cash flow margin | 0.00% | (1,332.36%) | 0.00% |
| Return on equity | (49.65%) | 1,211.66% | (56.36%) |
| Return on assets | (38.41%) | (92.03%) | (48.04%) |
| Return on invested capital | (64.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack